BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38684369)

  • 21. Design, synthesis and investigation of the mechanism of action underlying anti-leukemic effects of the quinolinequinones as LY83583 analogs.
    Ciftci HI; Bayrak N; Yıldız M; Yıldırım H; Sever B; Tateishi H; Otsuka M; Fujita M; Tuyun AF
    Bioorg Chem; 2021 Sep; 114():105160. PubMed ID: 34328861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis, and structure-activity relationships of novel benzothiazole derivatives bearing the ortho-hydroxy N-carbamoylhydrazone moiety as potent antitumor agents.
    Ma J; Chen D; Lu K; Wang L; Han X; Zhao Y; Gong P
    Eur J Med Chem; 2014 Oct; 86():257-69. PubMed ID: 25171780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and anticancer activity of some novel trifluoromethylquinolines carrying a biologically active benzenesulfonamide moiety.
    Al-Dosari MS; Ghorab MM; Alsaid MS; Nissan YM; Ahmed AB
    Eur J Med Chem; 2013 Nov; 69():373-83. PubMed ID: 24077528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 4-Flourophenyl-substituted 5H-indeno[1,2-b]pyridinols with enhanced topoisomerase IIα inhibitory activity: Synthesis, biological evaluation, and structure-activity relationships.
    Kunwar S; Hwang SY; Katila P; Seo M; Man Kadayat T; Kwon Y; Lee ES
    Bioorg Chem; 2021 Nov; 116():105349. PubMed ID: 34536927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and Anti-cancer Activity of 3-substituted Benzoyl-4-substituted Phenyl-1H-pyrrole Derivatives.
    Zhan X; Qin W; Wang S; Zhao K; Xin Y; Wang Y; Qi Q; Mao Z
    Anticancer Agents Med Chem; 2017; 17(6):821-831. PubMed ID: 27671311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Introducing novel potent anticancer agents of 1H-benzo[f]chromene scaffolds, targeting c-Src kinase enzyme with MDA-MB-231 cell line anti-invasion effect.
    Ahmed HEA; El-Nassag MAA; Hassan AH; Okasha RM; Ihmaid S; Fouda AM; Afifi TH; Aljuhani A; El-Agrody AM
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1074-1088. PubMed ID: 29923425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
    Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
    Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and evaluation of 3-(phenylethynyl)-1,1'-biphenyl-2-carboxylate derivatives as new HIF-1 inhibitors.
    Wang S; Wang X; Shao Y; Shao K; Wang Y; Guo X; Dong H; Zhao W; Li Y; Li G
    Bioorg Chem; 2021 Nov; 116():105298. PubMed ID: 34454298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New C2- and N3-Modified Thieno[2,3-d]Pyrimidine Conjugates with Cytotoxicity in the Nanomolar Range.
    Mavrova AT; Dimov S; Yancheva D; Rangelov M; Wesselinova D; Naydenova E
    Anticancer Agents Med Chem; 2022; 22(6):1201-1212. PubMed ID: 34315388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and antitumor activity of biotinylated camptothecin derivatives as potent cytotoxic agents.
    Zi CT; Yang L; Xu FQ; Dong FW; Ma RJ; Li Y; Zhou J; Ding ZT; Jiang ZH; Hu JM
    Bioorg Med Chem Lett; 2019 Jan; 29(2):234-237. PubMed ID: 30509782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel benzothiazole-based dual VEGFR-2/EGFR inhibitors targeting breast and liver cancers: Synthesis, cytotoxic activity, QSAR and molecular docking studies.
    Abd El-Meguid EA; Naglah AM; Moustafa GO; Awad HM; El Kerdawy AM
    Bioorg Med Chem Lett; 2022 Feb; 58():128529. PubMed ID: 35007724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and synthesis of new 7-(N-substituted-methyl)-camptothecin derivatives as potent cytotoxic agents.
    Zhao XB; Goto M; Song ZL; Morris-Natschke SL; Zhao Y; Wu D; Yang L; Li SG; Liu YQ; Zhu GX; Wu XB; Lee KH
    Bioorg Med Chem Lett; 2014 Aug; 24(16):3850-3. PubMed ID: 25008456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, Anticancer Activity on Prostate Cancer Cell Lines and Molecular Modeling Studies of Flurbiprofen-Thioether Derivatives as Potential Target of MetAP (Type II).
    Yılmaz Ö; Bayer B; Bekçi H; Uba AI; Cumaoğlu A; Yelekçi K; Küçükgüzel ŞG
    Med Chem; 2020; 16(6):735-749. PubMed ID: 31203805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and antiproliferative activity of some new thieno[2,3-d]pyrimidin-4(3H)-ones containing 1,2,4-triazole and 1,3,4-thiadiazole moiety.
    Mavrova ATs; Wesselinova D; Tsenov JA; Lubenov LA
    Eur J Med Chem; 2014 Oct; 86():676-83. PubMed ID: 25222878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, structure-activity relationship study and biological evaluation of the thieno[3,2-c]isoquinoline scaffold as a potential anti-cancer agent.
    Liu JT; Jaunky DB; Larocque K; Chen F; Mckibbon K; Sirouspour M; Taylor S; Shafeii A; Campbell D; Braga H; Piekny A; Forgione P
    Bioorg Med Chem Lett; 2021 Nov; 52():128327. PubMed ID: 34416378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, Synthesis, Structure-Activity Relationship and Docking Studies of Novel Functionalized Arylvinyl-1,2,4-Trioxanes as Potent Antiplasmodial as well as Anticancer Agents.
    Tiwari MK; Coghi P; Agrawal P; Shyamlal BRK; Jun Yang L; Yadav L; Peng Y; Sharma R; Yadav DK; Sahal D; Kam Wai Wong V; Chaudhary S
    ChemMedChem; 2020 Jul; 15(13):1216-1228. PubMed ID: 32392362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-Amino-2-aroylquinolines as highly potent tubulin polymerization inhibitors. Part 2. The impact of bridging groups at position C-2.
    Lee HY; Chang JY; Nien CY; Kuo CC; Shih KH; Wu CH; Chang CY; Lai WY; Liou JP
    J Med Chem; 2011 Dec; 54(24):8517-25. PubMed ID: 22060033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of N-(2-phenyl-1H-benzo[d]imidazol-5-yl)quinolin-4-amine derivatives as novel VEGFR-2 kinase inhibitors.
    Shi L; Wu TT; Wang Z; Xue JY; Xu YG
    Eur J Med Chem; 2014 Sep; 84():698-707. PubMed ID: 25064347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of dehydroxy isoquine and isotebuquine as promising anticancer agents targeting K+ channel.
    Romero AH; López SE; Arvelo F; Sojo F; Calderon C; Morales A
    Chem Biol Drug Des; 2019 Apr; 93(4):638-646. PubMed ID: 30570823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and in vitro evaluation of novel spiroketopyrazoles as acetyl-CoA carboxylase inhibitors and potential antitumor agents.
    Huang T; Wu X; Yan S; Liu T; Yin X
    Eur J Med Chem; 2021 Feb; 212():113036. PubMed ID: 33276990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.